share_log

Rain Oncology Q3 EPS $(0.19) Beats $(0.27) Estimate

Rain Oncology Q3 EPS $(0.19) Beats $(0.27) Estimate

Rain Oncology 第三季度每股收益(0.19 美元)高於美元(0.27)的預期
Benzinga ·  2023/11/09 16:49

Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 72.06 percent increase over losses of $(0.68) per share from the same period last year.

Rain Oncology(納斯達克股票代碼:RAIN)公佈季度每股虧損0.19美元,比分析師普遍估計的0.27美元(0.27美元)高出29.63%。這比去年同期每股虧損0.68美元(0.68美元)增加了72.06%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論